| PubMed |
Abstract |
RScore(About this table) |
| 8167334 |
Olivieri NF, Feig SA, Valentino L, Berriman AM, Shore R, Freedman MH: Failure of recombinant human interleukin-3 therapy to induce erythropoiesis in patients with refractory Diamond-Blackfan anemia. Blood. 1994 May 1;83(9):2444-50.
|
9(0,0,0,9) |
Details |
| 9705946 |
Wen TC, Tanaka J, Peng H, Desaki J, Matsuda S, Maeda N, Fujita H, Sato K, Sakanaka M: Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field. J Exp Med. 1998 Aug 17;188(4):635-49.
|
7(0,0,0,7) |
Details |
| 8967587 |
Soukup J, Menzel M, Roth S, Radke J: [The perioperative use of recombinant erythropoietin (rhEPO) in Jehovah's witnesses]. Anaesthesist. 1996 Aug;45(8):745-9.
Erythropoietin, the hematopoietic growth factor, is synthesised in the kidneys and liver and regulates red blood cell production.
After preoperative subcutaneous application of 5000 I.E. rhEPO three times per week and daily oral substitution of 300 mg ferrous sulfate over a period of 3 weeks, the Hb increased to 15.5 g/dl and the HCt to 49%. |
1(0,0,0,1) |
Details |